Phil joined Future Science Group as CEO in 2014 after a decade in senior management positions at Informa plc, where he ran Informa’s medical books and journals businesses. Since 2014 a significant part of Phil’s focus has been on nurturing the engagement and success of FSG’s Bioanalyisis journal–Bioanalysis Zone axis by providing enhanced value and relevance to the global bioanalytical community, whilst also replicating that across FSG’s other strength areas, such as nanomedicine, regenerative medicine and real-world evidence.
Phil is also on the board of FSG’s various philanthropic initiatives covering music, arts, literature and funding concussion research. He is also a Non-Executive Director at Portland Press Ltd, the publishing arm of the Biochemical Society.
Phil has a BSc in Zoology and an MBA – both from Imperial College London.
“If you want to go fast, go alone. If you want to go far, go together. But preferably, go fast and go together!”